<DOC>
	<DOCNO>NCT02028286</DOCNO>
	<brief_summary>The purpose study characterize pharmacokinetics daily topical gel confirm steady state condition reach maximal use condition follow 3 week daily application .</brief_summary>
	<brief_title>A 21 Day Pharmacokinetics Study Papulopustular Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>A diagnosis papulopustular rosacea Grade 3 4 5point Investigator Global Assessment scale Presence telangiectasia steroid rosacea subtype 3 ( phymatous rosacea ) clinically significant abnormal finding would interfere study objective risk safety subject . nodular rosacea ( lesion great 5mm 2 module )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Rosacea</keyword>
</DOC>